Correlation of first-trimester thymus size with chromosomal anomalies
Author:
Kleemann Sarah1, Koch Raphael2, Schmitz Ralf1, Köster Helen A.1, Braun Janina1, Steinhard Johannes3, Oelmeier Kathrin1, Klockenbusch Walter1, Möllers Mareike1
Affiliation:
1. Department of Obstetrics and Gynecology , University Hospital of Muenster , Muenster , Germany 2. Institute of Biostatistics and Clinical Research, University of Muenster , Muenster , Germany 3. Department of Fetal Cardiology , Heart and Diabetes Center North Rhine-Westphalia , Bad Oeynhausen , Germany
Abstract
Abstract
Objectives
The aim of this study was to investigate the correlation between fetal thymus size measured during first-trimester screening and chromosomal anomalies.
Methods
This study is a retrospective evaluation, in which the anterior-posterior diameter of the thymus in a midsagittal plane was measured in first-trimester ultrasound between 11+0 and 13+6 weeks of gestation in 168 fetuses with chromosomal anomalies (study group) and 593 healthy fetuses (control group). The included cases were subdivided into six groups: (1) trisomy 21, (2) trisomy 18, (3) trisomy 13, (4) Turner syndrome, (5) triploidy and (6) normal controls. Thymus size measurements were adjusted to the week of gestation, which was determined by ultrasound using crown-rump-length (CRL), by calculating a ratio between CRL and thymus size (CRL-thymus-ratio). Each study group was compared with the control group separately.
Results
Thymus size in fetuses affected by trisomy 18 or trisomy 13 was noticeably smaller compared to the control group (1.4 mm [1.3, 1.5] and 1.3 mm [1.2, 1.4] vs. 1.8 mm [1.6, 2.1]; all p<0.001; respectively). The thymus size of fetuses with trisomy 21 and Turner syndrome did not differ from healthy fetuses. Between the CRL-thymus-ratios of the separate study groups no statistically noticeable differences could be found.
Conclusions
Fetal thymus size appeared to be smaller in pregnancies affected by trisomy 18 and trisomy 13. The predictive value of fetal thymus size in first-trimester screening should be evaluated prospectively.
Publisher
Walter de Gruyter GmbH
Subject
Obstetrics and Gynaecology,Pediatrics, Perinatology, and Child Health
Reference26 articles.
1. Wagner, P, Sonek, J, Hoopmann, M, Abele, H, Kagan, KO. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan. Ultrasound Obstet Gynecol 2016;48:446–51. https://doi.org/10.1002/uog.15829. 2. Kagan, KO, Sonek, J, Wagner, P, Hoopmann, M. Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities. Arch Gynecol Obstet 2017;296:645–51. https://doi.org/10.1007/s00404-017-4459-9. 3. Gil, MM, Accurti, V, Santacruz, B, Plana, MN, Nicolaides, KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2017;50:302–14. https://doi.org/10.1002/uog.17484. 4. Farley, AM, Morris, LX, Vroegindeweij, E, Depreter, ML, Vaidya, H, Stenhouse, FH, et al.. Dynamics of thymus organogenesis and colonization in early human development. Development 2013;140:2015–26. https://doi.org/10.1242/dev.087320. 5. Schmitt, TM, Zúñiga-Pflücker, JC. T-cell development, doing it in a dish. Immunol Rev 2006;209:95–102. https://doi.org/10.1111/j.0105-2896.2006.00353.x.
|
|